What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
As the 15th AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved...
Imagine your DNA as a shoelace. What would happen to the ends if there were no aglets there to...
Black Americans are more than twice as likely to die from prostate cancer than white Americans, highlighting a major...
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
As we say goodbye to summer, enjoy the selection of articles handpicked by the editors of the AACR journals...
Although a basic assumption of genetics is that all the cells in our body share the same DNA, research...
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
The editors of the 10 AACR journals have selected a handful of must-read articles from the July issues. The...
The U.S. Centers for Disease Control and Prevention (CDC) estimate that 80 to 90 percent of deaths from lung...